Labor induction doesn’t always reduce caesarean birth risk or improve outcomes for term pregnancies

Statewide Michigan maternity care collaborative findings suggest need for thoughtful, equitable approach to inducing labor at 39 weeks of pregnancy

1:24 PM

Author | Beata Mostafavi

person pregnant with clock spinning over them in yellow purple background person in red pants pink shortsleeve shirt
Jacob Dwyer/Michigan Medicine

In recent years, experts have debated whether most birthing individuals would benefit from labor induction once they reach a certain stage of pregnancy.

But a statewide study in Michigan suggests that inducing labor at the 39th week of pregnancy for single baby first births in a head down position, or at low risk, won’t necessarily reduce the risk of caesarian births. In fact, it may even have the opposite effect if hospitals don’t take a thoughtful approach to induction policies.

“Some people in the field have suggested that after 39 weeks of gestation, medical induction should be standard practice,” said lead author Elizabeth Langen, M.D., a high-risk maternal fetal medicine physician and researcher at University of Michigan Health Von Voigtlander Women's Hospital at Michigan Medicine.

“We collaborated with peer hospitals to better understand how labor induction may influence cesarean birth outcomes in real world maternity units outside of a clinical trial. In our study sample, we found inducing labor in this population of women and birthing people did not reduce their risk of cesarean birth.”

The research, published in the American Journal of Perinatology, was based on more than 14,135 deliveries in 2020 analyzed through a statewide maternity care quality collaborative registry. The collaborative, known as the Obstetrics Initiative, began in 2018, includes at least 74 birthing hospitals and centers on reducing primary cesarean birth rates in low-risk pregnancies.

Results conflict with national trial findings

The study was conducted in response to published research in 2018 from a multicenter trial known as “ARRIVE” (A Randomized Trial of Induction Versus Expectant Management.)

Findings from ARRIVE indicated that medical induction at 39 weeks gestation in first time low risk pregnancies resulted in a lower rate of cesarean deliveries compared to expectant management – or waiting for labor to occur on its own or for a medical need for labor induction.

Michigan researchers mimicked the same framework used in the national trial and analyzed data from the collaborative’s data registry, comparing 1,558 patients who underwent a proactively induced labor versus 12,577 who experienced expectant management.

We designed an analytic framework mirroring the previous trial’s protocol using retrospective data, but our results didn’t reinforce a link between elective induced labor in late pregnancy and a reduction in caesarian births,” said senior author and U-M professor of nursing Lisa Kane Low, Ph.D., C.N.M., a midwife and researcher at Michigan Medicine and the U-M School of Nursing.

In fact, results from the general Michigan sample were contradictory to the ARRIVE trial: People who underwent elective induction were more likely to have a cesarean birth compared with those who underwent expectant management (30% versus 24%.)

In a subset of the sample, matching patient characteristics for a more refined analysis, there were no differences in c-section rates. Authors noted that time between admission and delivery was also longer for those induced.  

Expectantly managed women and birthing individuals were also less likely to have a postpartum hemorrhage (8% versus 10%) or operative vaginal delivery (9% versus 11%), whereas women who underwent induction were less likely to have a hypertensive disorder of pregnancy (6 % versus 9%.) There were no other differences in neonatal outcomes.

Authors point to several possible explanations for why the two studies had conflicting results. One key difference was that the Michigan study collected data after births for the purpose of quality improvement in a general population of low-risk births. The ARRIVE trial, however, used data collected in real time as part of a research study.

Inductions of labor for both medical indications and individual preferences will continue to be part of modern obstetrics, making it important to pursue strategies that optimize the induction process and outcomes."

- Elizabeth Langen, M.D.

A significant difference between individuals in a clinical trial and the general birthing population, Low says, may revolve around shared decision-making. Before trial enrollment, participants undergo a thorough informed consent process from trained study team members.

For the ARRIVE trial, this meant 72% of women approached to be in the study declined participation. Meanwhile, previous research has indicated that women in the general United States population often may feel pressured into agreeing to have their labor induced.

“Better outcomes may have occurred in the trial because the participants were fully accepting of this process,” Low said.

“Further research is needed to identify best practices to support people undergoing labor induction,” she added. “Prior to initiating an elective induction of labor policy, clinicians should also ensure resources and a process to fully support shared decision-making.”

Inequities impacting likelihood of induced labor

Michigan researchers also found that the practice of inducing labor at 39 weeks was not applied equally across demographic groups, with those being induced more likely to be birthing people who are at least 35 years old, identify as white non-Hispanic and who are privately insured.

The racial disparity in the data is consistent with the Centers for Disease Control and Prevention data that shows more white women undergo induced labor than birthing individuals of any other racial or ethnic group.

“These findings suggest that the practice of elective induction of labor may not be equitably applied across birthing people,” Langen said. “We can only speculate about the reasons for these differences, but it’s important that we pursue equitable application of evidence-based practices for all who would benefit.”

Hospitals across the Michigan collaborative varied in size, teaching status and location but the sample size for induced deliveries was not adequate to analyze the impact of specific hospital factors on outcomes, authors note.

However, the team’s additional analysis found cesarean birth rate after induced delivery did not differ between large hospitals and the rest of the collaborative.

“Inductions of labor for both medical indications and individual preferences will continue to be part of modern obstetrics, making it important to pursue strategies that optimize the induction process and outcomes,” Langen said. “Future work should include a health equity approach and include the voices of pregnant people and their experiences of changes in care management.”

Additional authors included Daniel Morgan, M.D., Charley Jiang, M.S., Amy Schiller, M.P.H., and Kathryn Moore, M.P.H., of U-M, and Althea Bourdeau, M.P.H., of  The Obstetrics Initiative in Ann Arbor, Mich.

Study cited: “Outcomes of Elective Induction of Labor at 39 Weeks from a Statewide Collaborative Quality Initiative,” American Journal of Perinatology. DOI:10.1055/s-0043-1761918


More Articles About: childbirth obstetrics and gynecology Von Voigtlander Women's Hospital Women's Health Race and Ethnicity Prenatal Care High-Risk Pregnancy Children's Health C.S. Mott Children’s Hospital Health Care Delivery, Policy and Economics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories
Health Lab
"Drawing Dad" becomes sensation throughout pediatric cancer unit
A form of art therapy for one dad brings joy to patients across his child's floor, also in-patient receiving treatments.
doctor checking heart on patient
Health Lab
Leading experts release new guidelines to improve congenital heart surgery care for children
For the first time in more than 20 years, dozens of pediatric cardiologists, surgeons and other health professionals have come together to develop new guidelines intended to improve heart surgery care for this population of children and teens.
woman older with provider
Health Lab
Should older adults, with fewer years to live, keep getting cancer screenings?
Cancer screening guidelines increasingly factor in how long a person has left to live, to guide whether to continue or stop screening. A new poll explores older adults’ attitudes toward this approach.
stork with baby in bag with dollar sign
Health Lab
Childbirth associated with significant medical debt
Postpartum individuals are more likely to have medical debt than those who are pregnant, suggests a Michigan Medicine led study that evaluated collections among a statewide commercially insured cohort of 14,560 pregnant people and 12,157 people in the postpartum period.
woman sitting and using cell pill crib teddy bear blue pink
Health Lab
A pill to treat postpartum depression? It’s here
The fast-acting postpartum pill offers more convenience than the postpartum depression infusion treatment, brexanolone (branded Zulresso), which has been available since 2019, but cost concerns remain. As with all mental health medications, zuranolone should be paired with psychosocial treatment to treat all factors contributing to the disease.
purple all notifications on phone teen sleeping in bed with phone next to them
Health Lab
Study: Average teen received more than 200 app notifications a day
A Michigan Medicine expert explains more of a report’s key findings on cell phone use and how parents can support a healthy use of technology.